Details

Autor(en) / Beteiligte

• Bellanti, Francesco
• Buglio, Aurelio Lo
• Stasio, Elena Di
• Bello, Giorgia di
• Tamborra, Rosanna
• Dobrakowski, Michał
• Kasperczyk, Aleksandra
• Kasperczyk, Sławomir
• Vendemiale, Gianluigi

Titel

An open-label, single-center pilot study to test the effects of an amino acid mixture in older patients admitted to internal medicine wards

Ist Teil von

• Nutrition (Burbank, Los Angeles County, Calif.), 2020-01, Vol.69, p.110588-110588, Article 110588

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2020

Quelle

MEDLINE

Beschreibungen/Notizen

• •We tested the effect of oral amino acids (AA) for 1 wk in older hospitalized patients.•AA reduced length of stay, 90-d postdischarge rehospitalization, and falls.•AA prevented the loss of muscle function owing to low mobility during hospitalization.•AA limited the increase of circulating interleukins and oxidative stress markers. Older patients are frequently subjected to prolonged hospitalization and extended bed rest, with a negative effect on physical activity and caloric intake. This results in a consistent loss of muscle mass and function, which is associated with functional decline and high mortality. The aim of this study was to investigate the effect of 1 wk of oral amino acid (AA) supplementation in older patients subjected to low mobility during hospitalization. Hospitalized older patients (69-87) were included in the control group (n = 50) or were administered 25 g of AA mixture (n = 44) twice daily throughout 7 d of low mobility. We collected data related to length of stay as primary outcome measure. In-hospital mortality, 90-d postdischarge mortality, 90-d postdischarge rehospitalization, and falls also were considered. Moreover, variations of anthropometric measures, body composition and muscle architecture/strength, circulating interleukins, and oxidative stress markers between the beginning and the end of the supplementation period were analyzed as secondary outcomes. Similar values were reported between the two groups regarding age (76.6 ± 6.8 versus 79 ± 7.2 y old), body weight (61.5 ± 14.3 versus 62.1 ± 16.1 kg), and body mass index (28.7 ± 4.15 versus 28.1 ± 3.62 kg/m2). Although no difference in terms of in-hospital, 90-d postdischarge, or overall mortality rate was observed between the two groups, a reduction in length of stay, 90-d postdischarge hospitalization, and falls was observed in the AA supplementation group rather than in controls. Furthermore, the AA mixture limited muscle architecture/strength impairment and circulating oxidative stress, which occurred during hospitalization-related bed rest. The latter data was associated with increased circulating levels of anti-inflammatory cytokines interleukin-4 and -10. These results suggest that the AA mixture limits several alterations associated with low mobility in older hospitalized patients, such as length of stay, 90-d postdischarge hospitalization, and falls, preventing the loss of muscle function, as well as the increase of circulating interleukins and oxidative stress markers.